Literature DB >> 7739048

Solution structure of human insulin-like growth factor II. Relationship to receptor and binding protein interactions.

A M Torres1, B E Forbes, S E Aplin, J C Wallace, G L Francis, R S Norton.   

Abstract

The three-dimensional structure of human insulin-like growth factor (IGF) II in aqueous solution at pH 3.1 and 300 K has been determined from nuclear magnetic resonance data and restrained molecular dynamics calculations. Structural constraints consisting of 502 NOE-derived distance constraints, 11 dihedral angle restraints, and three disulfide bridges were used as input for distance geometry calculations in DIANA and X-PLOR, followed by simulated annealing refinement and energy minimization in X-PLOR. The resulting family of 20 structures was well defined in the regions of residues 5 to 28 and 41 to 62, with an average pairwise root-mean-square deviation of 1.24 A for the backbone heavy-atoms (N, C2, C) and 1.90 A for all heavy atoms. The poorly defined regions consist of the N and C termini, part of the B-domain, and the C-domain loop. Resonances from these regions of the protein gave stronger cross peaks in two dimensional NMR spectra, consistent with significant motional averaging. The main secondary structure elements in IGF-II are alpha-helices encompassing residues 11 to 21, 42 to 49 and 53 to 59. A small anti-parallel beta-sheet is formed by residues 59 to 61 and 25 to 27, while residues 26 to 28 appear to participate in intermolecular beta-sheet formation. The structure of IGF-II in the well-defined regions is very similar to those of the corresponding regions of insulin and IGF-I. Significant differences between IGF-II and IGF-I occur near the start of the third helix, in a region known to modulate affinity for the type 2 IGF receptor, and at the C terminus. The IGF II structure is discussed in relation to its binding sites for the insulin and IGF receptors and the IGF binding proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739048     DOI: 10.1016/s0022-2836(95)80058-1

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  22 in total

1.  The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5.

Authors:  W Zesławski; H G Beisel; M Kamionka; W Kalus; R A Engh; R Huber; K Lang; T A Holak
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

Review 2.  Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.

Authors:  E Malito; R E Hulse; W-J Tang
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

Review 3.  Transcriptional regulation and biological significance of the insulin like growth factor II gene.

Authors:  W Engström; A Shokrai; K Otte; M Granérus; A Gessbo; P Bierke; A Madej; M Sjölund; A Ward
Journal:  Cell Prolif       Date:  1998 Oct-Dec       Impact factor: 6.831

Review 4.  Insulin: a small protein with a long journey.

Authors:  Qingxin Hua
Journal:  Protein Cell       Date:  2010-06       Impact factor: 14.870

5.  Solution structure of an ultra-stable single-chain insulin analog connects protein dynamics to a novel mechanism of receptor binding.

Authors:  Michael D Glidden; Yanwu Yang; Nicholas A Smith; Nelson B Phillips; Kelley Carr; Nalinda P Wickramasinghe; Faramarz Ismail-Beigi; Michael C Lawrence; Brian J Smith; Michael A Weiss
Journal:  J Biol Chem       Date:  2017-11-07       Impact factor: 5.157

6.  Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions.

Authors:  W Kalus; M Zweckstetter; C Renner; Y Sanchez; J Georgescu; M Grol; D Demuth; R Schumacher; C Dony; K Lang; T A Holak
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

7.  Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice.

Authors:  Jonathan H LeBowitz; Jeffrey H Grubb; John A Maga; Deborah H Schmiel; Carole Vogler; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

8.  Solution structure of a conformationally restricted fully active derivative of the human relaxin-like factor.

Authors:  Erika E Büllesbach; Mathias A S Hass; Malene R Jensen; D Flemming Hansen; Søren M Kristensen; Christian Schwabe; Jens J Led
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

9.  Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.

Authors:  Qing Guo; Marika Manolopoulou; Yao Bian; Alexander B Schilling; Wei-Jen Tang
Journal:  J Mol Biol       Date:  2009-11-05       Impact factor: 5.469

10.  A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II.

Authors:  Clair L Alvino; Kerrie A McNeil; Shee Chee Ong; Carlie Delaine; Grant W Booker; John C Wallace; Jonathan Whittaker; Briony E Forbes
Journal:  J Biol Chem       Date:  2009-01-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.